Skip to search formSkip to main contentSkip to account menu

ICI 170809

Known as: 2-Propanamine, N,N,2-trimethyl-1-((3-phenyl-2-quinolinyl)thio)-, ICI-170,809 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Quinolines
ZM 170809

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Platelet Ihydroxytryptamine is decreased in a preliminary group of depressed patients receiving the Ihydroxytryptamine reuptake inhi biting drug fluoxetine
1. In view of the importance of 5-hydroxytryptamine in coronary thrombosis, we wanted to know whether a potentially protective… 
1996
1996
Platelet 5-hydroxytryptamine is decreased in a preliminary group of depressed patients receiving the 5-hydroxytryptamine re-uptake inhibiting drug fluoxetine.
1. In view of the importance of 5-hydroxytryptamine in coronary thrombosis, we wanted to know whether a potentially protective… 
Highly Cited
1994
Highly Cited
1994
Further characterization of 5‐hydroxytryptamine receptors (putative 5‐HT2B) in rat stomach fundus longitudinal muscle
1 The present study was undertaken to isolate and characterize pharmacologically homogeneous populations of 5‐hydroxytryptamine… 
1993
1993
Collagen induced human platelet aggregation: serotonin receptor antagonism retards aggregate growth in vitro.
OBJECTIVE The role of platelet derived serotonin (5-HT) in collagen induced human platelet aggregation was examined both in… 
1993
1993
Interaction between the effects of 5‐hydroxytryptamine and adrenaline on the growth of platelet thrombi in the coronary artery of the anaesthetized dog
1 The interaction between adrenaline and 5‐hydroxytryptamine (5‐HT) has been quantitated on the rate of thrombus formation, in… 
1993
1993
Effects of chronic treatment with two selective 5-HT2 antagonists on sleep in the rat
Highly Cited
1990
Highly Cited
1990
Behavioural effects of serotonin agonists and antagonists in the rat and marmoset
1990
1990
ICI 170809, A selective 5-hydroxytryptamine antagonist, inhibits human platelet aggregation in vitro and ex vivo
In vitro 5-hydroxytryptamine (5-HT) cause both a shape and aggregation of human platelets. Few studies have been reported on 5-HT… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)